SPECIALIZED
VENTURES
Scientist-advisors for scientist-inventors specializing in computational drug discovery
OVERVIEW
Bellows Capital Partners is a specialized firm offering differentiated support to computational drug discovery companies. We are scientist-advisors for scientist-inventors. We specialize in seeing commercial opportunities in research technologies and helping scientists and entrepreneurs grow innovations out of the research lab.
Bellows Capital supports computational (e.g., AI/ML) technologies that can provide an immediate and tangible efficiency to the drug discovery process, ranging from target discovery to development. These technologies often move the “wet” lab to the computer.
Bellows produces support driven by fundamental analyses derived from scientific and commercial opportunities balanced with operational, regulatory, and financial risks. The Bellows Capital team’s combination of scientific, corporate, founder/operational, and financial experience allows the team to identify, execute, and realize opportunities in this specialized sector, with a specialized expertise.